DSM-FIRMENICH AG (ZX6.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:ZX6 - CH1216478797 - Common Stock
ZX6.DE Key Statistics, Chart & Performance
The current stock price of ZX6.DE is 71.26 EUR.
ZX6.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.11B | ||
| SY1.DE | SYMRISE AG | 19.38 | 9.83B | ||
| AKU1.DE | AKZO NOBEL N.V. | 14.9 | 9.27B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.04 | 9.37B | ||
| SYENS.BR | SYENSQO SA | 21.61 | 7.30B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.77 | 6.19B | ||
| AKE.PA | ARKEMA | 10.17 | 3.99B | ||
| NVJP.DE | UMICORE | 13 | 3.62B | ||
| UMI.BR | UMICORE | 12.8 | 3.56B | ||
| WCH.DE | WACKER CHEMIE AG | 156.63 | 3.51B | ||
| RBT.PA | ROBERTET SA | 18.64 | 1.90B | ||
| ACT.DE | ALZCHEM GROUP AG | 21.15 | 1.31B |
Related stock screener links
About ZX6.DE
Company Profile
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
Company Info
DSM-FIRMENICH AG
Wurmisweg 576, Kaiseraugst
Kaiseraugst AARGAU CH
Employees: 28608
DSM-FIRMENICH AG / ZX6.DE FAQ
What does DSM-FIRMENICH AG do?
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
What is the current price of ZX6 stock?
The current stock price of ZX6.DE is 71.26 EUR. The price increased by 0.17% in the last trading session.
What is the dividend status of DSM-FIRMENICH AG?
DSM-FIRMENICH AG (ZX6.DE) has a dividend yield of 3.59%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of ZX6 stock?
ZX6.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is ZX6.DE stock listed?
ZX6.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the Price/Earnings (PE) ratio of DSM-FIRMENICH AG (ZX6.DE)?
The PE ratio for DSM-FIRMENICH AG (ZX6.DE) is 75.81. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 71.26 EUR.
Is DSM-FIRMENICH AG (ZX6.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ZX6.DE.
ZX6.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ZX6.DE.
ZX6.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ZX6.DE. While ZX6.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
ZX6.DE Financial Highlights
Over the last trailing twelve months ZX6.DE reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -89.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.95% | ||
| ROA | 0.77% | ||
| ROE | 1.17% | ||
| Debt/Equity | 0.24 |
ZX6.DE Forecast & Estimates
30 analysts have analysed ZX6.DE and the average price target is 110.95 EUR. This implies a price increase of 55.7% is expected in the next year compared to the current price of 71.26.
For the next year, analysts expect an EPS growth of 19.53% and a revenue growth -0.86% for ZX6.DE